Pharmaceutical compound comprising a pyrazole derivative and methods of using the same for the treatment of calcium release-activated calcium channel associated diseases
申请人:Yamanouchi Pharmaceutical Co., Ltd.
公开号:US06348480B1
公开(公告)日:2002-02-19
The present invention is directed to drugs, in particular, pyrazole derivatives represented by the following general formula (I)
which have a calcium release-activated calcium channel inhibitory effect and medicinal compositions, in particular, calcium release-activated calcium channel inhibitors containing the above compounds as the active ingredient, wherein each substituent is defined in the specification.
The present invention also relates to a pharmaceutical composition containiing an effective amount of the compound of formula (I) and a pharmaceutically effective carrier.
The present invention further relates to methods of treatment of diseases associated with calcium release-activated calcium channels, diseases associated with IL-2 production, and methods of treatment of allergic, inflammatory or auto-immune diseases.
本发明涉及药物,特别是由以下一般式(I)表示的吡唑衍生物,其具有钙释放激活的钙通道抑制作用和药用组合物,特别是含有上述化合物作为活性成分的钙释放激活的钙通道抑制剂,其中每个取代基在规范中定义。本发明还涉及含有一定量的式(I)化合物和药效载体的药用组合物。本发明还涉及与钙释放激活的钙通道相关的疾病、与IL-2产生相关的疾病以及过敏、炎症或自身免疫疾病的治疗方法。